Obesity and survival in population-based patients with pancreatic cancer in the San Francisco Bay Area

Cancer Causes and Control

Volumn 23, Issue 12, 2012, Pages 1929-1937

  Gong, Zhihong ^a,b   Holly, Elizabeth A ^a   Bracci, Paige M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Obesity; Pancreatic cancer; Population based cohort; Survival

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PANCREAS CANCER; PATIENT ASSESSMENT; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; UNITED STATES;

AGED; AGED, 80 AND OVER; BODY MASS INDEX; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; PANCREATIC NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SAN FRANCISCO; SEER PROGRAM; SURVIVAL RATE; UNITED STATES;

EID: 84878852882     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-0070-3     Document Type: Article

References (42)

1. American Cancer Society. Cancer Facts & Figures 2011. Atlanta: American Cancer Society
2. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277-300
3. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D (2007) Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 335:1134
4. Genkinger JM, Spiegelman D, Anderson KE, Bernstein L, van den Brandt PA, Calle EE et al (2011) A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int J Cancer 129:1708-1717
5. Jiao L, Berrington de Gonzalez A, Hartge P, Pfeiffer RM, Park Y, Freedman DM et al (2010) Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts. Cancer Causes Control 21:1305-1314
6. Arslan AA, Helzlsouer KJ, Kooperberg C, Shu XO, Steplowski E, Bueno-de-Mesquita HB et al (2010) Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med 170:791-802
7. Stevens RJ, Roddam AW, Spencer EA, Pirie KL, Reeves GK, Green J et al (2009) Factors associated with incident and fatal pancreatic cancer in a cohort of middle-aged women. Int J Cancer 124:2400-2405
8. Coughlin SS, Calle EE, Patel AV, Thun MJ (2000) Predictors of pancreatic cancer mortality among a large cohort of United States adults. Cancer Causes Control 11:915-923
9. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625-1638
10. Li D, Morris JS, Liu J, Hassan MM, Day RS, Bondy ML et al (2009) Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA 301:2553-2562
11. Olson SH, Chou JF, Ludwig E, O'Reilly E, Allen PJ, Jarnagin WR et al (2010) Allergies, obesity, other risk factors and survival from pancreatic cancer. Int J Cancer 127:2412-2419
12. McWilliams RR, Matsumoto ME, Burch PA, Kim GP, Halfdanarson TR, de Andrade M et al (2010) Obesity adversely affects survival in pancreatic cancer patients. Cancer 116:5054-5062
13. Benns M, Woodall C, Scoggins C, McMasters K, Martin R (2009) The impact of obesity on outcomes following pancreatectomy for malignancy. Ann Surg Oncol 16:2565-2569
14. Williams TK, Rosato EL, Kennedy EP, Chojnacki KA, Andrel J, Hyslop T et al (2009) Impact of obesity on perioperative morbidity and mortality after pancreaticoduodenectomy. J Am Coll Surg 208:210-217
15. Noun R, Riachy E, Ghorra C, Yazbeck T, Tohme C, Abboud B et al (2008) The impact of obesity on surgical outcome after pancreaticoduodenectomy. Jop 9:468-476
16. House MG, Fong Y, Arnaoutakis DJ, Sharma R, Winston CB, Protic M et al (2008) Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. J Gastrointest Surg 12:270-278
17. Fleming JB, Gonzalez RJ, Petzel MQ, Lin E, Morris JS, Gomez H et al (2009) Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma. Arch Surg 144:216-221
18. Balentine CJ, Enriquez J, Fisher W, Hodges S, Bansal V, Sansgiry S et al (2010) Intra-abdominal fat predicts survival in pancreatic cancer. J Gastrointest Surg 14:1832-1837
19. Khan S, Sclabas G, Reid-Lombardo K, Sarr MG, Nagorney D, Kendrick ML et al (2010) Does body mass index/morbid obesity influence outcome in patients who undergo pancreatoduodenectomy for pancreatic adenocarcinoma? J Gastrointest Surg 14:1820-1825
20. Tsai S, Choti MA, Assumpcao L, Cameron JL, Gleisner AL, Herman JM et al (2010) Impact of obesity on perioperative outcomes and survival following pancreaticoduodenectomy for pancreatic cancer: a large single-institution study. J Gastrointest Surg 14:1143-1150
21. Gong Z, Holly EA, Bracci PM (2011) Survival in population-based pancreatic cancer patients: San Francisco Bay Area, 1995-1999. Am J Epidemiol 174:1373-1381
22. Holly EA, Eberle CA, Bracci PM (2003) Prior history of allergies and pancreatic cancer in the San Francisco Bay area. Am J Epidemiol 158:432-441
23. Cox DR (1972) Regression models with life-tables (with discussion). J Roy Stat Soc Ser B 34:187-220
24. Ramsey AM, Martin RC (2011) Body mass index and outcomes from pancreatic resection: a review and meta-analysis. J Gastrointest Surg 15:1633-1642
25. Ben Q, Xu M, Ning X, Liu J, Hong S, Huang W et al (2011) Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies. Eur J Cancer 47:1928-1937
26. Li D, Tang H, Hassan MM, Holly EA, Bracci PM, Silverman DT (2011) Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies. Cancer Causes Control 22:189-197
27. Lynch SM, Vrieling A, Lubin JH, Kraft P, Mendelsohn JB, Hartge P et al (2009) Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol 170:403-413
28. Ansary-Moghaddam A, Huxley R, Barzi F, Lawes C, Ohkubo T, Fang X et al (2006) The effect of modifiable risk factors on pancreatic cancer mortality in populations of the Asia-Pacific region. Cancer Epidemiol Biomarkers Prev 15:2435-2440
29. Wang F, Gupta S, Holly EA (2006) Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California. Cancer Epidemiol Biomarkers Prev 15:1458-1463
30. Bosetti C, Lucenteforte E, Silverman DT et al (2011) Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Ann Oncol 22:1420-1426
31. Tranah GJ, Holly EA, Wang F, Bracci PM (2011) Cigarette, cigar and pipe smoking, passive smoke exposure, and risk of pancreatic cancer: a population-based study in the San Francisco Bay Area. BMC Cancer 11:138
32. Godsland IF (2010) Insulin resistance and hyperinsulinaemia in the development and progression of cancer. Clin Sci (Lond) 118:315-332
33. Kahn BB, Flier JS (2000) Obesity and insulin resistance. J Clin Invest 106:473-481
34. Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840-846
35. Mossner J, Logsdon CD, Goldfine ID, Williams JA (1987) Do insulin and the insulin like growth factors (IGFs) stimulate growth of the exocrine pancreas? Gut 28(Suppl):51-55
36. Margetic S, Gazzola C, Pegg GG, Hill RA (2002) Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 26:1407-1433
37. White PB, True EM, Ziegler KM, Wang SS, Swartz-Basile DA, Pitt HA et al (2010) Insulin, leptin, and tumoral adipocytes promote murine pancreatic cancer growth. J Gastrointest Surg 14:1888-1893 (discussion 1893-1894)
38. Becker S, Dossus L, Kaaks R (2009) Obesity related hyperinsulinaemia and hyperglycaemia and cancer development. Arch Physiol Biochem 115:86-96
39. Skibola CF, Holly EA, Forrest MS, Hubbard A, Bracci PM, Skibola DR et al (2004) Body mass index, leptin and leptin receptor polymorphisms, and non-hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 13:779-786
40. Ramos EJ, Xu Y, Romanova I et al (2003) Is obesity an inflammatory disease? Surgery 134:329-335
41. Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G (2006) Inflammation and cancer: how hot is the link? Biochem Pharmacol 72:1605-1621
42. Kulbe H, Thompson R, Wilson JL, Robinson S, Hagemann T, Fatah R et al (2007) The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Cancer Res 67:585-592